Smaller product manufacturers are tapping Europe as a way to get their devices to market, a study by Northwestern University researchers has discovered. An investigation of more than 350 professionals found that two-thirds of the companies are seeking approvals in Europe first. This suggests, they said, a “delayed market entry” in the United States. The perceived unpredictability of the Food and Drug Administration’s approval process is the most commonly cited reason for the shift.